Sunwoo, John
Zavriyev, Alexander I.
Kaya, Kutlu
Martin, Alyssa
Munster, Chelsea
Steele, Tina
Cuddyer, Deborah
Sheldon, Yvonne
Orihuela-Espina, Felipe
Herzberg, Emily M.
Inder, Terrie
Franceschini, Maria Angela
El-Dib, Mohamed
Funding for this research was provided by:
National Institutes of Health (R01HD091067)
Article History
Received: 22 March 2022
Accepted: 11 July 2022
First Online: 27 July 2022
Change Date: 1 August 2022
Change Type: Update
Change Details: The original online version of this Article was revised: In the original version of this Article the Supplementary Information file contained tracked changes, these have now been removed.
Competing interests
: The authors, except MAF, declare no conflicts of interest in this work. MAF has a financial interest in 149 Medical, Inc., a company developing DCS technology for assessing and monitoring cerebral blood flow in newborn infants. MAF’s interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham in accordance with their conflict of interest policies.